Literature DB >> 15728221

High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care.

Barrie R Cassileth, Andrew J Vickers.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15728221     DOI: 10.1200/JCO.2005.11.922

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  39 in total

1.  Complementary and alternative medicine use among cancer survivors: a population-based study.

Authors:  Jun James Mao; Christina Shearer Palmer; Kaitlin Elizabeth Healy; Krupali Desai; Jay Amsterdam
Journal:  J Cancer Surviv       Date:  2010-10-06       Impact factor: 4.442

2.  Complementary and alternative medicines use by Scottish women with breast cancer. What, why and the potential for drug interactions?

Authors:  J S McLay; D Stewart; J George; C Rore; S D Heys
Journal:  Eur J Clin Pharmacol       Date:  2011-12-14       Impact factor: 2.953

Review 3.  Putting Integrative Oncology Into Practice: Concepts and Approaches.

Authors:  Shelly Latte-Naor; Jun J Mao
Journal:  J Oncol Pract       Date:  2019-01       Impact factor: 3.840

4.  Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).

Authors:  Christine B Ambrosone; Gary R Zirpoli; Alan D Hutson; William E McCann; Susan E McCann; William E Barlow; Kara M Kelly; Rikki Cannioto; Lara E Sucheston-Campbell; Dawn L Hershman; Joseph M Unger; Halle C F Moore; James A Stewart; Claudine Isaacs; Timothy J Hobday; Muhammad Salim; Gabriel N Hortobagyi; Julie R Gralow; George T Budd; Kathy S Albain
Journal:  J Clin Oncol       Date:  2019-12-19       Impact factor: 44.544

5.  Integrative oncology: really the best of both worlds?

Authors:  David H Gorski
Journal:  Nat Rev Cancer       Date:  2014-10       Impact factor: 60.716

6.  Managing Patient Expectations: Integrative, Not Alternative.

Authors:  Shelly Latte-Naor
Journal:  Cancer J       Date:  2019 Sep/Oct       Impact factor: 3.360

7.  Any difference? Use of a CAM provider among cancer patients, coronary heart disease (CHD) patients and individuals with no cancer/CHD.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  BMC Complement Altern Med       Date:  2012-01-12       Impact factor: 3.659

8.  Influence of family on expected benefits of complementary and alternative medicine (CAM) in cancer patients.

Authors:  Shelly Latte-Naor; Robert Sidlow; Lingyun Sun; Qing S Li; Jun J Mao
Journal:  Support Care Cancer       Date:  2018-01-24       Impact factor: 3.603

9.  Complementary and alternative medicine in patients with chronic lymphocytic leukemia.

Authors:  Manfred Hensel; Martin Zoz; Anthony D Ho
Journal:  Support Care Cancer       Date:  2008-05-06       Impact factor: 3.603

10.  Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.

Authors:  Jin Ge; Jessica Fishman; Neha Vapiwala; Susan Q Li; Krupali Desai; Sharon X Xie; Jun J Mao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-03       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.